1. W.D. Wilson, in: E. Kool, D. Barton, K. Nakanishi (Eds.), DNA and RNA intercalators: DNA and aspects of molecular biology, Comprehensive Natural Products Chemistry, Vol. 7, 1998 (Chapter 8).
2. DNA intercalating ligands as anticancer drugs: prospect for future design;Denny;Anticancer Drug Des.,1989
3. A. Bodley, L.F. Liu, M. Israel, R. Seshadri, Y. Koseki, F.C. Giuliani, S. Kirschenbaum, R. Silber, M. Potmesil, DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA, Cancer Res. (1990) 5969–5978.
4. Different modes of anthracycline interaction with topoisomerase II: separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistance;Jensen;Biochem. Pharmacol.,1993
5. Potential antitumor agents: 30. mutagenic activity of some 9-anilinoacridines: relationship between structure, mutagenic potential and antileukemic activity;Ferguson;J. Med. Chem.,1979